久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

• Search
• HOME
• CHINA
• WORLD
• BUSINESS
• LIFESTYLE
• CULTURE
• TRAVEL
• VIDEO
• SPORTS
• OPINION
• REGIONAL
• FORUM
• NEWSPAPER
• MOBILE

Global EditionASIA 中文雙語Fran?ais

1. Home
2. World
/ Europe

CureVac fails in COVID-19 vaccine trial with 47% efficacy

By Ouyang Xueyan | chinadaily.com.cn | Updated: 2021-06-18 00:04

Share

Share - WeChat

CLOSE

German biotech CureVac's COVID-19 vaccine has come out of a late-stage trial with 47 percent efficacy but the health ministry has said this will not impact the country's vaccination rollout.

Photos

Israel's airports authority says reopens airspace

Iran-Israel ceasefire begins: Iranian TV

Iranian state media says fifth missile wave fired at northern Israel

ICE raids scare workers away

Experts doubt new Canada-US trade deal can be reached in 30 days

China and neighboring countries' economic development mutually providing chances: UN expert

Most Viewed in 24 Hours

World in Focus

Ancient echoes, new voices

Across Asia +

Tech rescue

ASEAN nations brace for US tariffs with bold measures

Special Coverage +

Live: Israel says missiles from Iran amid ceasefire, Iran denies

My China Album

Friends Afar +

Ballet maestro's fond China memories

Ties That Bind +

Vital pass to boost China-Pakistan trade

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

License for publishing multimedia online 0108263

Registration Number: 130349

About China Daily

Advertise on Site

Contact Us

Job Offer

Expat Employment

FOLLOW US